To evaluate the long-term prognostic impact of plasma Epstein-Barr virus ( EBV ) DNA concentration measured by real-time quantitative polymerase chain reaction ( RTQ-PCR ) in nasopharyngeal carcinoma ( NPC ) patients receiving concurrent chemoradiotherapy ( CCRT ) .
